502 related articles for article (PubMed ID: 32341579)
41. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
[TBL] [Abstract][Full Text] [Related]
42. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
43. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
Packer RJ; Biegel JA; Blaney S; Finlay J; Geyer JR; Heideman R; Hilden J; Janss AJ; Kun L; Vezina G; Rorke LB; Smith M
J Pediatr Hematol Oncol; 2002; 24(5):337-42. PubMed ID: 12142780
[TBL] [Abstract][Full Text] [Related]
44. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Johann P; Wu G; Billups CA; Tatevossian RG; Dhanda SK; Srinivasan A; Broniscer A; Qaddoumi I; Vinitsky A; Armstrong GT; Bendel AE; Hassall T; Partap S; Fisher PG; Crawford JR; Chintagumpala M; Bouffet E; Gururangan S; Mostafavi R; Sanders RP; Klimo P; Patay Z; Indelicato DJ; Nichols KE; Boop FA; Merchant TE; Kool M; Ellison DW; Gajjar A
Clin Cancer Res; 2021 May; 27(10):2879-2889. PubMed ID: 33737307
[TBL] [Abstract][Full Text] [Related]
45. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
Deisch J; Raisanen J; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
[TBL] [Abstract][Full Text] [Related]
47. Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?
Oh CC; Orr BA; Bernardi B; Garré ML; Rossi A; Figà-Talamanca L; Robinson GW; Patay Z
J Neurooncol; 2015 Sep; 124(2):175-83. PubMed ID: 26148473
[TBL] [Abstract][Full Text] [Related]
48. Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group.
van Gool SW; Holm S; Rachor J; Adamson L; Technau A; Maass E; Frühwald MC; Schlegel PG; Eyrich M
Cytotherapy; 2016 Sep; 18(9):1178-86. PubMed ID: 27421737
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.
Oka H; Scheithauer BW
Neurol Med Chir (Tokyo); 1999 Jul; 39(7):510-7; discussion 517-8. PubMed ID: 10437379
[TBL] [Abstract][Full Text] [Related]
50. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.
Sommer C; Boldajipour B; Kuo TC; Bentley T; Sutton J; Chen A; Geng T; Dong H; Galetto R; Valton J; Pertel T; Juillerat A; Gariboldi A; Pascua E; Brown C; Chin SM; Sai T; Ni Y; Duchateau P; Smith J; Rajpal A; Van Blarcom T; Chaparro-Riggers J; Sasu BJ
Mol Ther; 2019 Jun; 27(6):1126-1138. PubMed ID: 31005597
[TBL] [Abstract][Full Text] [Related]
51. Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice.
Mulazzani M; Fräßle SP; von Mücke-Heim I; Langer S; Zhou X; Ishikawa-Ankerhold H; Leube J; Zhang W; Dötsch S; Svec M; Rudelius M; Dreyling M; von Bergwelt-Baildon M; Straube A; Buchholz VR; Busch DH; von Baumgarten L
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24275-24284. PubMed ID: 31712432
[TBL] [Abstract][Full Text] [Related]
52. CAR-T cells for pediatric brain tumors: Present and future.
Leruste A; Beccaria K; Doz F
Bull Cancer; 2021 Oct; 108(10S):S109-S116. PubMed ID: 34920793
[TBL] [Abstract][Full Text] [Related]
53. Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors.
Balakrishnan A; Rajan A; Salter AI; Kosasih PL; Wu Q; Voutsinas J; Jensen MC; Plückthun A; Riddell SR
Clin Cancer Res; 2019 Dec; 25(24):7506-7516. PubMed ID: 31548346
[TBL] [Abstract][Full Text] [Related]
54. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.
Vitanza NA; Wilson AL; Huang W; Seidel K; Brown C; Gustafson JA; Yokoyama JK; Johnson AJ; Baxter BA; Koning RW; Reid AN; Meechan M; Biery MC; Myers C; Rawlings-Rhea SD; Albert CM; Browd SR; Hauptman JS; Lee A; Ojemann JG; Berens ME; Dun MD; Foster JB; Crotty EE; Leary SES; Cole BL; Perez FA; Wright JN; Orentas RJ; Chour T; Newell EW; Whiteaker JR; Zhao L; Paulovich AG; Pinto N; Gust J; Gardner RA; Jensen MC; Park JR
Cancer Discov; 2023 Jan; 13(1):114-131. PubMed ID: 36259971
[TBL] [Abstract][Full Text] [Related]
55. Brain atypical teratoid rhabdoid tumor in an adult with long-term survival: Case report and review of literature.
Moujahed R; Ghedira K; Zehani A; Charfi S; Nagi S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S243-S245. PubMed ID: 33380689
[TBL] [Abstract][Full Text] [Related]
56. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
57. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
58. A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes.
Schäfer D; Henze J; Pfeifer R; Schleicher A; Brauner J; Mockel-Tenbrinck N; Barth C; Gudert D; Al Rawashdeh W; Johnston ICD; Hardt O
Front Immunol; 2020; 11():1704. PubMed ID: 32849600
[TBL] [Abstract][Full Text] [Related]
59. Does Stereotactic Radiosurgery Positively Impact the Local Control of Atypical Teratoid Rhabdoid Tumors?
Spina A; Gagliardi F; Boari N; Bailo M; Mortini P
World Neurosurg; 2017 Aug; 104():612-618. PubMed ID: 28461278
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant chemotherapy for atypical teratoid rhabdoid tumors: case report.
Thatikunta M; Mutchnick I; Elster J; Thompson MP; Huang MA; Spalding AC; Moriarty T
J Neurosurg Pediatr; 2017 May; 19(5):546-552. PubMed ID: 28291373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
